Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists

被引:36
作者
Allenet, B
Barry, H
机构
[1] CHU Grenoble, Grenoble Sch Pharm, Dept Clin Pharm, F-38700 La Tronche, France
[2] CRESGE Labores, CNRS, URA362, F-59016 Lille, France
来源
PHARMACY WORLD & SCIENCE | 2003年 / 25卷 / 05期
关键词
behaviour; community pharmacist; France; generic drugs; opinion; professional identity; strategy substitution;
D O I
10.1023/A:1025840920988
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: In 1999, a new law was introduced, giving French pharmacists the right to switch from branded to generic drugs, unless the prescriber had specified that substitution was not permitted. The purpose of this study was to assess the opinion and behaviour of community pharmacists towards substitution. Design: Self-completion, postal close-ended questionnaires were filled out. Sample and setting: 1,000 French community pharmacists were included. Results: 90% of the pharmacists were favourable to the implementation of the substitution right. 42.5% declared they systematically offered patients the generic drug, whereas 55% chose to target specific populations for substitution. The reluctance of pharmacists could be commercial ('How do I get paid for the time spent? Is it worth risking loosing a customer?'), or cultural ('How do I work this out? Who should I offer generic drugs to? What strategy should I use to offer them?'). Conclusion: Generic drug distribution is very recent in France and is not yet common practice. Pharmacists and patients must be informed and trained because substitution is a collaborative act. It does not depend solely on the will and experience of pharmacists.
引用
收藏
页码:197 / 202
页数:6
相关论文
共 14 条
[1]  
ALLAERT F, 1998, J EC MED, V16, P93
[2]  
Andersen M L, 2000, Ugeskr Laeger, V162, P6066
[3]  
BARRY H, 2001, NOUVELLES PHARM, V373, P557
[4]  
Ganther J M, 2000, J Am Pharm Assoc (Wash), V40, P378
[5]   A comparative analysis of generics markets in five European countries [J].
Garattini, L ;
Tediosi, F .
HEALTH POLICY, 2000, 51 (03) :149-162
[6]  
MARTIN E, 1998, EC STAT, V312, P55
[7]  
Meunier J., 1999, Annales Pharmaceutiques Francaises, V57, P340
[8]  
NORDLING S, 2000, HUR GICK FORSOKET ME
[9]   The role of the Danish community pharmacist: perceptions and future scenarios [J].
Norgaard, LS ;
Colberg, L ;
Niemann, MR .
PHARMACY WORLD & SCIENCE, 2001, 23 (04) :159-164
[10]  
Pelton L E, 1994, J Hosp Mark, V9, P137